Neurocrine Bioscience buy StockNews.com
Start price
23.09.23
/
50%
€107.85
Target price
23.09.24
-
Performance (%)
-3.38%
End price
24.09.24
€104.20
Summary
This prediction ended on 24.09.24 with a price of €104.20. With a performance of -3.38%, the BUY prediction by StockNews_com finished with a loss. StockNews_com has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Neurocrine Bioscience | -2.217% | -2.217% | -4.920% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by StockNews_com for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten